Methylphenidate for core and ADHD-like symptoms in children aged 6 to 18 years with autism spectrum disorders (ASDs)
Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group
Published Online: 13 AUG 2014
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Redman T, Scheermeyer E, Ogawa M, Sparks EC, Taylor JC, Tran VT, Sturman N, van Driel ML. Methylphenidate for core and ADHD-like symptoms in children aged 6 to 18 years with autism spectrum disorders (ASDs) (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 8. Art. No.: CD011144. DOI: 10.1002/14651858.CD011144.
- Publication Status: New
- Published Online: 13 AUG 2014
This is the protocol for a review and there is no abstract. The objectives are as follows:
To determine the efficacy and safety of methylphenidate for 1) features of ADHD such as hyperactivity, impulsivity, and concentration, and 2) the core features of ASD (social, communication, and behavioural problems) in children aged six to 18 years with ASD.